Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Drugs For Herpes Labialis (Oral Herpes) Consumption 2016 Market Research Report

  • QYR902341
  • 140 Pages
  • January 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
The global drugs for herpes labialis (oral herpes) market research report 2016 is a professional and in-depth study on the current state of the drugs for herpes labialis (oral herpes) market. Annual estimates and forecasts are provided for the period 2015 through 2021. Also, a six-year historic analysis is provided for these markets. The global market for drugs for herpes labialis (oral herpes) is expected to reach about 5460 M USD by 2021 from 1920 M USD in 2016, registering a compounded annual growth rate (CARG) of 5.1% during the analysis period, 2016-2021.

This report studies sale of drugs for herpes labialis (oral herpes) in global market, especially in North America, Europe, China, Rest of Asia, focuses on top players in these regions, with revenue and market share for each player in these regions, covering

GSK

Novartis

Teva

Mylan

Cadila

Apotex

Daewoong Pharmaceutical

Livzon

Luoxin

Med shine

Bayer (Campho Phenique)

Blistex

Kelun Group

Hikma

Haiwang

Carmex

Cipher

Market Segment by regions, this report splits global into several key regions, with sales (consumption), revenue, and market share and growth rate of drugs for herpes labialis (oral herpes) in these regions, from 2011 to 2021 (forecast), like

North America

Europe

China

Rest of Asia

Split by product types, with Sales, Revenue, Price, and market share and growth rate of each type, can be divided into

Valacyclovir

Aciclovir

Famciclovir

Docosanol

Other

Split by applications, this report focuses on sales, market share and growth rate of drugs for herpes labialis (oral herpes) in each application, can be divided into

External Use

Oral

Injection

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market

Table of Contents

1 Drugs for Herpes Labialis (Oral Herpes) Overview 1

1.1 Product Overview and Scope of Drugs for Herpes Labialis (Oral Herpes) 1

1.1.1 Definition of Drugs for Herpes Labialis (Oral Herpes) 1

1.1.2 Specifications of Drugs for Herpes Labialis (Oral Herpes) 2

1.2 Classification of Drugs for Herpes Labialis (Oral Herpes) 3

1.2.1 Valacyclovir 4

1.2.2 Aciclovir 4

1.2.3 Famciclovir 5

1.2.4 Docosanol 6

1.3 Applications of Drugs for Herpes Labialis (Oral Herpes) 7

1.3.1 External Use 8

1.3.2 Oral 8

1.3.3 Injection 9

1.4 Drugs for Herpes Labialis (Oral Herpes) Market by Regions 10

1.4.1 North America Status and Prospect (2011-2021) 10

1.4.2 Europe Status and Prospect (2011-2021) 11

1.4.3 China Status and Prospect (2011-2021) 11

1.4.4 Rest of Asia Status and Prospect (2011-2021) 12

1.5 Global Market Size (Value) of Drugs for Herpes Labialis (Oral Herpes) (2011-2021) 12

1.5.1 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Gross Margin (2011-2021) 12

1.5.2 Global Drugs for Herpes Labialis (Oral Herpes) Gross and Growth Rate (2011-2021) 13

1.5.3 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2021) 14

2 Global Drugs for Herpes Labialis (Oral Herpes) Competition by Manufacturers, Type and Application 15

2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Competition by Manufacturers 15

2.1.1 Global Drugs for Herpes Labialis (Oral Herpes) Gross and Market Share of Key Manufacturers (2015-2016) 15

2.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Share by Manufacturers (2015-2016) 18

2.2 Global Drugs for Herpes Labialis (Oral Herpes) (Volume and Value) by Type 21

2.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Gross and Market Share by Type (2011-2016) 21

2.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Type (2011-2016) 23

2.3 Global Drugs for Herpes Labialis (Oral Herpes) (Volume and Value) by Regions 25

2.3.1 Global Drugs for Herpes Labialis (Oral Herpes) Gross and Market Share by Regions (2011-2016) 25

2.3.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Regions (2011-2016) 27

2.4 Global Drugs for Herpes Labialis (Oral Herpes) (Volume) by Application 29

3 North America Drugs for Herpes Labialis (Oral Herpes) (Volume, Value and Gross Price) 31

3.1 North America Drugs for Herpes Labialis (Oral Herpes) Gross and Value (2011-2016) 31

3.1.1 North America Drugs for Herpes Labialis (Oral Herpes) Gross and Growth Rate (2011-2016) 31

3.1.2 North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2016) 32

3.1.3 North America Drugs for Herpes Labialis (Oral Herpes) Gross Margin (2011-2016) 33

3.2 North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Manufacturers 33

3.3 North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Type 34

3.4 North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Applications 35

4 China Drugs for Herpes Labialis (Oral Herpes) (Volume, Value and Gross Price) 36

4.1 China Drugs for Herpes Labialis (Oral Herpes) Gross and Value (2011-2016) 36

4.1.1 China Drugs for Herpes Labialis (Oral Herpes) Gross and Growth Rate (2011-2016) 36

4.1.2 China Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2016) 37

4.1.3 China Drugs for Herpes Labialis (Oral Herpes) Gross Margin (2011-2016) 38

4.2 China Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Manufacturers 38

4.3 China Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Type 39

4.4 China Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Applications 40

5 Europe Drugs for Herpes Labialis (Oral Herpes) (Volume, Value and Gross Price) 41

5.1 Europe Drugs for Herpes Labialis (Oral Herpes) Gross and Value (2011-2016) 41

5.1.1 Europe Drugs for Herpes Labialis (Oral Herpes) Gross and Growth Rate (2011-2016) 41

5.1.2 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2016) 42

5.1.3 Europe Drugs for Herpes Labialis (Oral Herpes) Gross Margin (2011-2016) 43

5.2 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Manufacturers 43

5.3 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Type 44

5.4 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Applications 45

6 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) (Volume, Value and Gross Price) 46

6.1 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Gross and Value (2011-2016) 46

6.1.1 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Gross and Growth Rate (2011-2016) 46

6.1.2 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2016) 47

6.1.3 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Gross Margin (2011-2016) 48

6.2 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Manufacturers 48

6.3 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Type 49

6.4 Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Applications 50

7 Analysis of Drugs for Herpes Labialis (Oral Herpes) Industry Key Manufacturers 51

7.1 GSK 51

7.1.1 Company Profile 51

7.1.2 Product Information 52

7.1.3 Revenue, Cost, Gross, and Gross Margin 53

7.2 Novartis 54

7.2.1 Company Profile 54

7.2.2 Product Information 55

7.2.3 Revenue, Cost, Gross, and Gross Margin 55

7.3 Teva 56

7.3.1 Company Profile 56

7.3.2 Product Information 57

7.3.3 Revenue, Cost, Gross, and Gross Margin 59

7.4 Mylan 59

7.4.1 Company Profile 59

7.4.2 Product Information 60

7.4.3 Revenue, Cost, Gross, and Gross Margin 62

7.5 Cadila 62

7.5.1 Company Profile 62

7.5.2 Product Information 63

7.5.3 Revenue, Cost, Gross, and Gross Margin 64

7.6 Apotex 64

7.6.1 Company Profile 64

7.6.2 Product Information 65

7.6.3 Revenue, Cost, Gross, and Gross Margin 66

7.7 Daewoong 66

7.7.1 Company Profile 66

7.7.2 Product Information 67

7.7.3 Revenue, Cost, Gross, and Gross Margin 68

7.8 Livzon 68

7.8.1 Company Profile 68

7.8.2 Product Information 69

7.8.3 Revenue, Cost, Gross, and Gross Margin 70

7.9 Luoxin 70

7.9.1 Company Profile 70

7.9.2 Product Information 72

7.9.3 Revenue, Cost, Gross, and Gross Margin 72

7.10 Med shine 73

7.10.1 Company Profile 73

7.10.2 Product Information 74

7.10.3 Revenue, Cost, Gross, and Gross Margin 74

7.11 Bayer (Campho Phenique) 75

7.11.1 Company Profile 75

7.11.2 Product Information 76

7.11.3 Revenue, Cost, Gross, and Gross Margin 76

7.12 Blistex 77

7.12.1 Company Profile 77

7.12.2 Product Information 78

7.12.3 Revenue, Cost, Gross, and Gross Margin 78

7.13 Kelun Group 79

7.13.1 Company Profile 79

7.13.2 Product Information 80

7.13.3 Revenue, Cost, Gross, and Gross Margin 80

7.14 Hikma 81

7.14.1 Company Profile 81

7.14.2 Product Information 82

7.14.3 Revenue, Cost, Gross, and Gross Margin 82

7.15 Haiwang 82

7.15.1 Company Profile 82

7.15.2 Product Information 83

7.15.3 Revenue, Cost, Gross, and Gross Margin 84

7.16 Carmex 84

7.16.1 Company Profile 84

7.16.2 Product Information 85

7.16.3 Revenue, Cost, Gross, and Gross Margin 85

7.17 Cipher 86

7.17.1 Company Profile 86

7.17.2 Product Information 87

7.17.3 Revenue, Cost, Gross, and Gross Margin 87

8 Drugs for Herpes Labialis (Oral Herpes) Manufacturing Cost Analysis 88

8.1 Drugs for Herpes Labialis (Oral Herpes) Key Raw Materials and Manufacturing Equipment Analysis 88

8.1.1 Drugs for Herpes Labialis (Oral Herpes) Key Raw Materials Analysis 88

8.1.2 Drugs for Herpes Labialis (Oral Herpes) Key Manufacturing Equipment Analysis 89

8.2 Proportion of Manufacturing Cost Structure 91

8.2.1 Raw Materials 91

8.2.2 Labor Cost Analysis of Drugs for Herpes Labialis (Oral Herpes) 91

8.2.3 Other Costs Analysis 98

8.3 Manufacturing Process Analysis of Drugs for Herpes Labialis (Oral Herpes) 103

9 Industrial Chain, Sourcing Strategy and Downstream Buyers 104

9.1 Drugs for Herpes Labialis (Oral Herpes) Industrial Chain Analysis 104

9.2 Upstream Raw Materials Sourcing 104

9.3 Raw Materials Sources of Drugs for Herpes Labialis (Oral Herpes) Major Manufacturers 105

9.4 Downstream Buyers 106

10 Marketing Strategy Analysis, Distributors/Traders 108

10.1 Marketing Channel 108

10.2 Market Positioning 109

10.2.1 Pricing Strategy 109

10.2.2 Brand Strategy 109

10.2.3 Target Client 109

10.3 Distributors/Traders List 109

11 Market Effect Factors Analysis 111

11.1 Market Drivers 111

11.2 Consumer Needs/Customer Preference Change 111

11.3 Economic/Political Environmental Change 111

11.3.1 Global Economy Analysis 112

11.3.2 Europe Economy Analysis 113

11.3.3 Japan Economy Analysis 114

11.3.4 China Economy Analysis 115

11.3.5 USA Economy Analysis 117

12 Global Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2016-2021) 118

12.1 Global Drugs for Herpes Labialis (Oral Herpes) Gross, Revenue Forecast (2016-2021) 118

12.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Regions (2016-2021) 119

12.3 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Type (2016-2021) 120

12.4 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Application (2016-2021) 120

13 Conclusion of the Global Drugs for Herpes Labialis (Oral Herpes) Market Report 2016 121

14 Appendix 122

Author List 122

Disclosure Section 123

Research Methodology 123

Data Source 124

Disclaimer 124

List of Tables and Figures

Figure Picture of Drugs for Herpes Labialis (Oral Herpes) 1

Table Specifications of Drugs for Herpes Labialis (Oral Herpes) 2

Table Classification Comparison of Different Types of Drugs for Herpes Labialis (Oral Herpes) 3

Figure Global Revenue (M USD) Market Share of Drugs for Herpes Labialis (Oral Herpes) by Type in 2015 3

Figure Valacyclovir Picture 4

Figure Aciclovir Picture 4

Figure Famciclovir Picture 5

Figure Docosanol Picture 6

Figure Applications of Drugs for Herpes Labialis (Oral Herpes) 7

Figure Global Revenue (M USD) Market Share of Drugs for Herpes Labialis (Oral Herpes) by Application in 2015 8

Figure External Use Examples 8

Figure Oral Examples 9

Figure Injection Examples 9

Figure North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2021) 10

Figure Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2021) 11

Figure China Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2021) 11

Figure Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2021) 12

Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) and Gross Margin (2011-2016) 12

Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) and Gross Margin (2016-2021) 13

Figure Global Drugs for Herpes Labialis (Oral Herpes) Gross and Growth Rate (2011-2021) 13

Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2021) 14

Table Global Drugs for Herpes Labialis (Oral Herpes) Gross (M USD) of Key Manufacturers (2015-2016) 15

Table Global Drugs for Herpes Labialis (Oral Herpes) Gross Share by Manufacturers (2015-2016) 16

Figure 2015 Drugs for Herpes Labialis (Oral Herpes) Gross Share by Manufacturers 17

Figure 2016 Drugs for Herpes Labialis (Oral Herpes) Gross Share by Manufacturers 18

Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Manufacturers (2015-2016) 18

Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Manufacturers (2015-2016) 19

Figure 2015 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Manufacturers 20

Figure 2016 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Manufacturers 21

Table Global Drugs for Herpes Labialis (Oral Herpes) Gross (M USD) by Type (2011-2016) 22

Table Global Drugs for Herpes Labialis (Oral Herpes) Gross Share by Type (2011-2016) 22

Figure Gross Market Share of Drugs for Herpes Labialis (Oral Herpes) by Type (2011-2016) 22

Figure Global Drugs for Herpes Labialis (Oral Herpes) Gross Growth Rate by Type (2011-2016) 23

Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Type (2011-2016) 23

Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2011-2016) 23

Figure Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Type (2011-2016) 24

Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate by Type (2011-2016) 25

Table Global Drugs for Herpes Labialis (Oral Herpes) Gross (M USD) by Regions (2011-2016) 25

Table Global Drugs for Herpes Labialis (Oral Herpes) Gross Share by Regions (2011-2016) 26

Figure Gross Market Share of Drugs for Herpes Labialis (Oral Herpes) by Regions (2011-2016) 26

Figure Global Drugs for Herpes Labialis (Oral Herpes) Gross Growth Rate by Regions (2011-2016) 27

Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Regions (2011-2016) 27

Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Regions (2011-2016) 27

Figure Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Regions (2011-2016) 28

Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate by Regions (2011-2016) 29

Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Application (2011-2016) 29

Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2011-2016) 29

Figure Revenue Market Share of Drugs for Herpes Labialis (Oral Herpes) by Application (2011-2016) 30

Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate by Application (2011-2016) 30

Figure North America Drugs for Herpes Labialis (Oral Herpes) Gross and Growth Rate (2011-2016) 31

Figure North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2016) 32

Figure North America Drugs for Herpes Labialis (Oral Herpes) Gross Margin (2011-2016) 33

Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Manufacturers (2015-2016) 33

Table North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Manufacturers (2015-2016) 34

Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Type (2015-2016) 34

Table North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2015-2016) 35

Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Applications (2015-2016) 35

Table North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Applications (2015-2016) 35

Figure China Drugs for Herpes Labialis (Oral Herpes) Gross and Growth Rate (2011-2016) 36

Figure China Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2016) 37

Figure China Drugs for Herpes Labialis (Oral Herpes) Gross Margin (2011-2016) 38

Table China Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Manufacturers (2015-2016) 38

Table China Drugs for Herpes Labialis (Oral Herpes) Market Share by Manufacturers (2015-2016) 39

Table China Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Type (2015-2016) 39

Table China Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2015-2016) 40

Table China Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Applications (2015-2016) 40

Table China Drugs for Herpes Labialis (Oral Herpes) Market Share by Applications (2015-2016) 40

Figure Europe Drugs for Herpes Labialis (Oral Herpes) Gross and Growth Rate (2011-2016) 41

Figure Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2016) 42

Figure Europe Drugs for Herpes Labialis (Oral Herpes) Gross Margin (2011-2016) 43

Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Manufacturers (2015-2016) 43

Table Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Manufacturers (2015-2016) 44

Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Type (2015-2016) 44

Table Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2015-2016) 45

Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Applications (2015-2016) 45

Table Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Applications (2015-2016) 45

Figure Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Gross and Growth Rate (2011-2016) 46

Figure Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2011-2016) 47

Figure Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Gross Margin (2011-2016) 48

Table Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Manufacturers (2015-2016) 48

Table Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Market Share by Manufacturers (2015-2016) 49

Table Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Type (2015-2016) 49

Table Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2015-2016) 50

Table Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) by Applications (2015-2016) 50

Table Rest of Asia Drugs for Herpes Labialis (Oral Herpes) Market Share by Applications (2015-2016) 50

Table GSK Company Profile 51

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of GSK 52

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of GSK 53

Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of GSK 2015-2016 53

Table Novartis Company Profile 54

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Novartis 55

Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Novartis 2015-2016 55

Table Teva Company Profile 56

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Teva 57

Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Teva 2015-2016 59

Table Mylan Company Profile 59

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Mylan 60

Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Mylan 2015-2016 62

Table Cadila Company Profile 62

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Cadila 63

Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Cadila 2015-2016 64

Table Apotex Company Profile 64

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Apotex 65

Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Apotex 2015-2016 66

Table Daewoong Company Profile 66

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Daewoong 67

Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Daewoong 2015-2016 68

Table Livzon Company Profile 68

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Livzon 69

Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Livzon 2015-2016 70

Table Luoxin Company Profile 70

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Luoxin 72

Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Luoxin 2015-2016 72

Table Med shine Company Profile 73

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Med shine 74

Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Med shine 2015-2016 74

Table Bayer (Campho Phenique) Company Profile 75

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Bayer (Campho Phenique) 76

Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Bayer (Campho Phenique) 2015-2016 76

Table Blistex Company Profile 77

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Blistex 78

Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Blistex 2015-2016 78

Table Kelun Group Company Profile 79

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Kelun Group 80

Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Kelun Group 2015-2016 80

Table Hikma Company Profile 81

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Hikma 82

Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Hikma 2015-2016 82

Table Haiwang Company Profile 82

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Haiwang 83

Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Haiwang 2015-2016 84

Table Carmex Company Profile 84

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Carmex 85

Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Carmex 2015-2016 85

Table Cipher Company Profile 86

Figure Drugs for Herpes Labialis (Oral Herpes) Product Introductions of Cipher 87

Table Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Cipher 2015-2016 87

Table Key Raw Materials Suppliers 88

Table Manufacturing Cost Structure of Drugs for Herpes Labialis (Oral Herpes) 91

Figure USA Overview of Average Hourly Wages 2015-2016 (USD/Hour) 92

Figure USA Overview of Labor Costs 2013-2016 (110 Index Points) 92

Figure Cost of Employing a Factory Worker 94

Figure 2015 Estimated Labour Costs for the Whole Economy in EuropeR 95

Figure Monthly Minimum Wages in Asia 2016 96

Figure China Overview of Average Yearly Wages 2015-2016 (CNY/Year) 97

Figure Japan Overview of Average Monthly Wages 2015-2016(JPY Thousand/Month) 97

Table Average Price of Electricity to Ultimate Customers 98

Figure Electricity Prices for Household Consumers in 2015 100

Figure Summary of the Driving Assumptions 101

Figure Industrial Electric Rates 2015 (PER KWH) 101

Figure Manufacturing Process Analysis of Drugs for Herpes Labialis (Oral Herpes) 103

Figure Drugs for Herpes Labialis (Oral Herpes) Industrial Chain Analysis 104

Table Major Raw Materials Suppliers with Contact Information of Drugs for Herpes Labialis (Oral Herpes) 105

Table Major Buyers of Drugs for Herpes Labialis (Oral Herpes) 106

Figure Marketing Channels of Drugs for Herpes Labialis (Oral Herpes) 108

Table Distributors/Traders List 109

Table Market Drivers of Drugs for Herpes Labialis (Oral Herpes) 111

Figure Global GDP Map 2014 112

Figure EU GDP Change 2005-2014 113

Figure German CPI Change 2011-2015 113

Figure UK CPI Change 2011-2015 114

Figure Japan GDP Change 2005-2014 114

Figure Japan CPI Change 2005-2014 115

Figure China GDP Change 2005-2014 115

Figure China CPI Change 2005-2014 116

Figure China PPI Growth Rate 2005-2014 116

Figure US GDP Change 2005-2014 117

Figure US CPI Change 2011-2015 117

Figure Global Drugs for Herpes Labialis (Oral Herpes) Gross and Growth Rate Forecast (2016-2021) 118

Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate Forecast (2016-2021) 119

Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) Forecast by Regions (2016-2021) 119

Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) Forecast by Type (2016-2021) 120

Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue (M USD) Forecast by Application (2016-2021) 120

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
View Details
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370
View Details
Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research